U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Subperiosteal bone resorption

MedGen UID:
1380263
Concept ID:
C4476534
Anatomical Abnormality
Synonym: Subperiosteal erosions
 
HPO: HP:0003106

Definition

Loss of bone mass occurring beneath the periosteum (the periosteum is the connective-tissue membrane that surrounds all bones except at the articular surfaces). This process may create a serrated and lace-like appearance in periosteal cortical bone. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVSubperiosteal bone resorption

Conditions with this feature

Vitamin D-dependent rickets, type 1
MedGen UID:
124344
Concept ID:
C0268689
Disease or Syndrome
Vitamin D-dependent rickets is a disorder of bone development that leads to softening and weakening of the bones (rickets). There are several forms of the condition that are distinguished primarily by their genetic causes: type 1A (VDDR1A), type 1B (VDDR1B), and type 2A (VDDR2A). There is also evidence of a very rare form of the condition, called type 2B (VDDR2B), although not much is known about this form.\n\nThe signs and symptoms of vitamin D-dependent rickets begin within months after birth, and most are the same for all types of the condition. The weak bones often cause bone pain and delayed growth and have a tendency to fracture. When affected children begin to walk, they may develop abnormally curved (bowed) legs because the bones are too weak to bear weight. Impaired bone development also results in widening of the areas near the ends of bones where new bone forms (metaphyses), especially in the knees, wrists, and ribs. Some people with vitamin D-dependent rickets have dental abnormalities such as thin tooth enamel and frequent cavities. Poor muscle tone (hypotonia) and muscle weakness are also common in this condition, and some affected individuals develop seizures.\n\nIn vitamin D-dependent rickets, there is an imbalance of certain substances in the blood. An early sign in all types of the condition is low levels of the mineral calcium (hypocalcemia), which is essential for the normal formation of bones and teeth. Affected individuals also develop high levels of a hormone involved in regulating calcium levels called parathyroid hormone (PTH), which leads to a condition called secondary hyperparathyroidism. Low levels of a mineral called phosphate (hypophosphatemia) also occur in affected individuals. Vitamin D-dependent rickets types 1 and 2 can be grouped by blood levels of a hormone called calcitriol, which is the active form of vitamin D; individuals with VDDR1A and VDDR1B have abnormally low levels of calcitriol and individuals with VDDR2A and VDDR2B have abnormally high levels.\n\nHair loss (alopecia) can occur in VDDR2A, although not everyone with this form of the condition has alopecia. Affected individuals can have sparse or patchy hair or no hair at all on their heads. Some affected individuals are missing body hair as well.
Vitamin D-dependent rickets type II with alopecia
MedGen UID:
90989
Concept ID:
C0342646
Disease or Syndrome
Vitamin D-dependent rickets type 2A (VDDR2A) is caused by a defect in the vitamin D receptor gene. This defect leads to an increase in the circulating ligand, 1,25-dihydroxyvitamin D3. Most patients have total alopecia in addition to rickets. VDDR2B (600785) is a form of vitamin D-dependent rickets with a phenotype similar to VDDR2A but a normal vitamin D receptor, in which end-organ resistance to vitamin D has been shown to be caused by a nuclear ribonucleoprotein that interferes with the vitamin D receptor-DNA interaction. For a general phenotypic description and a discussion of genetic heterogeneity of rickets due to disorders in vitamin D metabolism or action, see vitamin D-dependent rickets type 1A (VDDR1A; 264700).

Professional guidelines

PubMed

Bedrossian E, Bedrossian EA
Int J Oral Maxillofac Implants 2018 Sep/Oct;33(5):e135-e145. doi: 10.11607/jomi.6539. PMID: 30231096
Seeman E
Osteoporos Int 2003;14 Suppl 3:S2-8. Epub 2003 Mar 19 doi: 10.1007/s00198-002-1340-9. PMID: 12730770
Bazzi C, Arrigo G, Luciani L, Casazza F, Saviotti M, Malaspina D, Bonucci E, Ballanti P, Amaducci S, Lattuada P
Clin Nephrol 1995 Aug;44(2):96-107. PMID: 8529316

Recent clinical studies

Etiology

Castellano E, Attanasio R, Boriano A, Borretta V, Gennaro M, Latina A, Borretta G
Endocr Pract 2020 Sep;26(9):983-989. doi: 10.4158/EP-2020-0095. PMID: 33471703
Mokarram Hossain R, Iqbal MM, Hoque ME, Rahman MH, Ur Rashid H
Hemodial Int 2005 Oct;9 Suppl 1:S21-4. doi: 10.1111/j.1542-4758.2005.01166.x. PMID: 16223439
Polat P, Kantarci M, Alper F, Koruyucu M, Suma S, Onbaş O
Clin Imaging 2002 May-Jun;26(3):197-205. doi: 10.1016/s0899-7071(01)00386-2. PMID: 11983474
Ito K, Aoki J, Kobayashi S, Karakida O, Seo GS, Serizawa S, Sone S, Sugenoya A, Iida F
Radiology 1994 Aug;192(2):497-502. doi: 10.1148/radiology.192.2.8029422. PMID: 8029422
Mohini R, Dumler F, Rao DS
ASAIO Trans 1991 Oct-Dec;37(4):635-7. PMID: 1768501

Diagnosis

Taguchi T, Terada Y
N Engl J Med 2014 May 22;370(21):e32. doi: 10.1056/NEJMicm1308814. PMID: 24849102
Lacativa PG, Franco FM, Pimentel JR, Patrício Filho PJ, Gonçalves MD, Farias ML
Sao Paulo Med J 2009 May;127(2):71-7. doi: 10.1590/s1516-31802009000200004. PMID: 19597681Free PMC Article
Mokarram Hossain R, Iqbal MM, Hoque ME, Rahman MH, Ur Rashid H
Hemodial Int 2005 Oct;9 Suppl 1:S21-4. doi: 10.1111/j.1542-4758.2005.01166.x. PMID: 16223439
Jiménez-Montero JG, Lobo-Hernández E, Picado-Larios A, Molina MA
Endocr Pract 2002 Nov-Dec;8(6):429-32. doi: 10.4158/EP.8.6.429. PMID: 15260008
Parisien M, Silverberg SJ, Shane E, Dempster DW, Bilezikian JP
Endocrinol Metab Clin North Am 1990 Mar;19(1):19-34. PMID: 2192867

Therapy

Roux S, Massicotte MH, Huot Daneault A, Brazeau-Lamontagne L, Dufresne J
Bone 2019 Mar;120:482-486. Epub 2018 Dec 17 doi: 10.1016/j.bone.2018.12.012. PMID: 30572144
Jiménez-Montero JG, Lobo-Hernández E, Picado-Larios A, Molina MA
Endocr Pract 2002 Nov-Dec;8(6):429-32. doi: 10.4158/EP.8.6.429. PMID: 15260008
Robinson C, Baker N, Noble J, King A, David G, Sillence D, Hofman P, Cundy T
J Inherit Metab Dis 2002 Dec;25(8):681-93. doi: 10.1023/a:1022935115323. PMID: 12705498
Trachtman H, Gauthier B
J Pediatr 1987 Jun;110(6):966-70. doi: 10.1016/s0022-3476(87)80426-2. PMID: 3585613
Silverberg DS, Bettcher KB, Dossetor JB, Overton TR, Holick MF, DeLuca HF
Can Med Assoc J 1975 Jan 25;112(2):190, 193-5. PMID: 1111876Free PMC Article

Prognosis

Mohini R, Dumler F, Rao DS
ASAIO Trans 1991 Oct-Dec;37(4):635-7. PMID: 1768501

Clinical prediction guides

Castellano E, Attanasio R, Boriano A, Borretta V, Gennaro M, Latina A, Borretta G
Endocr Pract 2020 Sep;26(9):983-989. doi: 10.4158/EP-2020-0095. PMID: 33471703
Jiménez-Montero JG, Lobo-Hernández E, Picado-Larios A, Molina MA
Endocr Pract 2002 Nov-Dec;8(6):429-32. doi: 10.4158/EP.8.6.429. PMID: 15260008
Mohini R, Dumler F, Rao DS
ASAIO Trans 1991 Oct-Dec;37(4):635-7. PMID: 1768501
Burnstein MI, Kottamasu SR, Pettifor JM, Sochett E, Ellis BI, Frame B
Radiology 1985 May;155(2):351-6. doi: 10.1148/radiology.155.2.3983385. PMID: 3983385

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...